Interactive Brokers closed at $76.62, up 16% over the past month, though the stock fell 6.2% this week. Short interest dropped 23% from March highs while analysts lifted price targets across the board, creating a mean target of $85.70—12% above current levels.
IBKR closed at $76.62 on April 24, up 0.9% on the day. The stock fell 6.2% over the past week but has rallied 16% over the past month. This recent pullback follows a strong multi-week advance that brought the shares to their highest level since early April.
Short interest stands at 10.19 million shares, representing 2.29% of the free float as of April 23. This marks a 23% decline from month-ago levels when short sellers held 13.21 million shares. The position dropped sharply in early April, falling from 12.15 million shares on April 2 to 9.94 million by April 17. Over the past week, short interest crept back up 1%, adding roughly 100,000 shares. Days to cover sits at 2.38 according to the most recent FINRA data from April 15.
Cost to borrow collapsed to 0.13% on April 23, down 47% week-over-week and 57% from the 0.31% level recorded a month ago. The metric hit 0.60% on April 2 before plunging to 0.08% on April 21. Utilisation remains subdued at 0.93%, well below the 52-week high of 9.49%. The reading has hovered under 1% for most of the past week, down from 1.61% on March 24.
The put-call ratio registered 0.62 on April 24, in line with the 20-day mean of 0.62. The z-score of -0.08 indicates near-neutral sentiment. The current reading sits well within the 52-week range of 0.19 to 9.32. Over the past month, the PCR has trended lower, falling from 0.77 in mid-March to the current sub-0.62 level.
Four major firms raised price targets on April 22 following an earnings-related catalyst. James Yaro at Goldman Sachs lifted his target from $89 to $98 while maintaining a Buy rating. Brennan Hawken at BMO Capital raised his Outperform-rated target from $80 to $93. Benjamin Budish at Barclays moved his Overweight target from $85 to $93, while Patrick Moley at Piper Sandler increased his Overweight target from $80 to $88.
Earlier in April, Daniel Fannon at Jefferies cut his Buy-rated target from $91 to $81 on April 6. Chris Allen at Keefe, Bruyette & Woods reinstated coverage with a Market Perform rating and $75 target on April 8. The consensus price target of $85.70 implies 12% upside from current levels.
The P/E ratio stands at 29.0, up 1.7 points over the past 30 days. The price-to-book ratio sits at 2.34, down 2.4 points from month-ago levels. The enterprise value reached $5.68 billion, climbing $306 million over the past month.
Interactive Brokers scores in the 91st percentile for dividend quality and the 83rd percentile for sector score. EPS momentum over 30 days ranks at the 78th percentile, while the 90-day reading sits at the 62nd percentile. The short score ranks in the 63rd percentile. EPS surprise comes in at the 59th percentile, and 12-month forward EPS growth sits at the 28th percentile.
Vanguard added 1.15 million shares in Q1, bringing its stake to 52.25 million shares (11.7% of the company). BlackRock increased its position by 711,000 shares to 31.66 million (7.1%). State Street added 213,000 shares, now holding 18.84 million (4.2%). Norges Bank boosted its stake by 1.91 million shares to 7.05 million (1.58%).
W1M Asset Management increased its holding by 5.28 million shares in Q4, reaching 5.86 million shares (1.32%). Egerton Capital added 685,000 shares to hold 6.94 million (1.56%). Greenwich Wealth Management trimmed 1.18 million shares, reducing its position to 9.19 million (2.06%). Founder Thomas Peterffy holds 6.06 million shares (1.36%) with no change reported since April 2025.
Insiders sold a net $30.7 million worth of shares over the past 90 days, representing 400,100 shares. Executive Vice Chairman Earl Nemser accounted for the bulk of activity, selling 300,000 shares across eight transactions between January 23 and January 27 at prices ranging from $75.07 to $78.14. The sales totaled $23.05 million.
Director Lori Conkling made three small purchases in February, March, and April, buying 100 shares for a combined $7,100. Her April 1 purchase of 25 shares at $68.38 marked the most recent insider transaction.
The company has four earnings-related events scheduled in late April according to available data, with the most recent announcement on April 21. No forward-looking earnings date is provided in the snapshot. The dividend data is stale, with the last recorded payment of $0.10 dating to May 2022.
This analysis is for informational purposes only and does not constitute financial advice. ORTEX data as of April 25, 2026.
See the live data behind this article on ORTEX.
Open IBKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
